Ignite Creation Date:
2024-05-05 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 9:39 AM
Study NCT ID:
NCT00579865
Status:
COMPLETED
Last Update Posted:
2010-01-14
First Post:
2007-12-20
Brief Title:
Quality Of Life in Patients With Malignant Biliary Obstruction
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Impact of Biliary Drainage on Quality Of Life in Patients With Malignant Biliary Obstruction
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
You may have symptoms like itching abdominal pain loss of appetite fatigue fevers and chills The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life
Detailed Description:
Malignant biliary obstruction MBO may arise in patients with cholangiocarcinoma pancreatic carcinoma primary gallbladder carcinoma hepatocellular carcinoma or metastatic disease to the liver or portal lymph nodes MBO is often accompanied by significant symptoms that may result in impairment of health-related quality of life HRQL including pruritus fever nutritional deficits abdominal pain nausea and vomiting and fatigue Approaches to the relief of MBO include surgical bypass andor resection percutaneous drainage with or without biliary stenting or endoscopic stenting The non surgical procedures may be done prior to attempted curative resection or for palliation in individuals with unresectable or recurrent disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None